Zhejiang pharmaceutical companies enter 10 billion blockbuster varieties!

A few days ago, the official website of the State Food and Drug Administration showed that Zhejiang Lepu Pharmaceutical’s acarbose tablets were submitted for approval in the imitation of 4 types of acarbose tablets.

According to data, Acarbose tablets are an alpha-glycosidase inhibitor developed by Bayer, which is mainly used in combination with diet control to treat type 2 diabetes and reduce the postprandial blood sugar of people with impaired glucose tolerance.

Overall sales of acarbose tablets

Source: Minet database

According to data from Meinenet, in 2019, the total sales of acarbose tablets in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) terminals and Chinese urban physical pharmacies terminals totaled nearly 100 100 million yuan.

Source: MED2.

In terms of consistency evaluation, acarbose tablets have been reviewed by 7 pharmaceutical companies.

Source: official website of the State Food and Drug Administration, Mi Nei.